JP2014527025A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014527025A5 JP2014527025A5 JP2014512110A JP2014512110A JP2014527025A5 JP 2014527025 A5 JP2014527025 A5 JP 2014527025A5 JP 2014512110 A JP2014512110 A JP 2014512110A JP 2014512110 A JP2014512110 A JP 2014512110A JP 2014527025 A5 JP2014527025 A5 JP 2014527025A5
- Authority
- JP
- Japan
- Prior art keywords
- right ventricular
- patient
- vasoactive agent
- determining whether
- indicator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002550 vasoactive agent Substances 0.000 claims 8
- 206010013012 Dilatation ventricular Diseases 0.000 claims 6
- 208000008166 Right Ventricular Dysfunction Diseases 0.000 claims 6
- 230000006814 right ventricular dysfunction Effects 0.000 claims 6
- 230000000004 hemodynamic effect Effects 0.000 claims 4
- 230000036593 pulmonary vascular resistance Effects 0.000 claims 4
- 230000000747 cardiac effect Effects 0.000 claims 3
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 claims 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims 2
- 206010064911 Pulmonary arterial hypertension Diseases 0.000 claims 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 claims 2
- 239000011149 active material Substances 0.000 claims 1
- 230000004872 arterial blood pressure Effects 0.000 claims 1
- 239000003638 chemical reducing agent Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 229940127293 prostanoid Drugs 0.000 claims 1
- 150000003814 prostanoids Chemical class 0.000 claims 1
- 210000001147 pulmonary artery Anatomy 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161490929P | 2011-05-27 | 2011-05-27 | |
| US61/490,929 | 2011-05-27 | ||
| PCT/US2012/039401 WO2012166534A1 (en) | 2011-05-27 | 2012-05-24 | Method of determining vasoreactivity using inhaled nitric oxide |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017061811A Division JP2017165731A (ja) | 2011-05-27 | 2017-03-27 | 吸入用一酸化窒素を用いて血管反応性を決定する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014527025A JP2014527025A (ja) | 2014-10-09 |
| JP2014527025A5 true JP2014527025A5 (cg-RX-API-DMAC7.html) | 2015-08-27 |
Family
ID=47259769
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014512110A Pending JP2014527025A (ja) | 2011-05-27 | 2012-05-24 | 吸入用一酸化窒素を用いて血管反応性を決定する方法 |
| JP2017061811A Ceased JP2017165731A (ja) | 2011-05-27 | 2017-03-27 | 吸入用一酸化窒素を用いて血管反応性を決定する方法 |
| JP2019035311A Pending JP2019131556A (ja) | 2011-05-27 | 2019-02-28 | 吸入用一酸化窒素を用いて血管反応性を決定する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017061811A Ceased JP2017165731A (ja) | 2011-05-27 | 2017-03-27 | 吸入用一酸化窒素を用いて血管反応性を決定する方法 |
| JP2019035311A Pending JP2019131556A (ja) | 2011-05-27 | 2019-02-28 | 吸入用一酸化窒素を用いて血管反応性を決定する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11154210B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2713723B1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2014527025A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012262534B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2837341C (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012166534A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7618594B2 (en) | 2004-08-18 | 2009-11-17 | Geno Llc | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
| AU2005277397B2 (en) | 2004-08-18 | 2011-08-25 | VERO Biotech LLC. | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
| JP5554723B2 (ja) | 2008-01-28 | 2014-07-23 | ゲノ エルエルシー | 二酸化窒素（ｎｏ２）から一酸化窒素（ｎｏ）への変換 |
| US8607785B2 (en) | 2008-08-21 | 2013-12-17 | Geno Llc | Systems and devices for generating nitric oxide |
| EP2445508B1 (en) | 2009-06-22 | 2018-11-14 | VERO Biotech LLC | Nitric oxide therapies |
| CA2837341C (en) | 2011-05-27 | 2021-10-19 | Geno Llc | Method of determining vasoreactivity using inhaled nitric oxide |
| EP3407675B1 (en) | 2014-04-15 | 2022-03-09 | CommScope Technologies LLC | Wideband remote unit for distributed antenna system |
| EP3970730B1 (en) * | 2016-02-12 | 2024-05-01 | Mallinckrodt Pharmaceuticals Ireland Limited | System for use and monitoring of inhaled nitric oxide with left ventricular assist devices |
| MX2019009931A (es) | 2017-02-27 | 2020-07-14 | Third Pole Inc | Sistemas y metodos para generacion ambulatoria de oxido nitrico. |
| CN113620263A (zh) | 2017-02-27 | 2021-11-09 | 第三极股份有限公司 | 生成一氧化氮的系统和方法 |
| MX2020010523A (es) | 2017-02-27 | 2021-02-09 | Third Pole Inc | Sistemas y metodos para generar oxido nitrico. |
| US11672938B1 (en) | 2018-07-18 | 2023-06-13 | Vero Biotech LLC | Start-up protocols for nitric oxide delivery device |
| US20210386944A1 (en) * | 2018-10-12 | 2021-12-16 | Sanotize Research Development Corp. | Gas-evolving compositions and container and delivery systems |
| WO2020232397A1 (en) | 2019-05-15 | 2020-11-19 | Third Pole, Inc. | Electrodes for nitric oxide generation |
| WO2020232419A1 (en) | 2019-05-15 | 2020-11-19 | Third Pole, Inc. | Systems and methods for generating nitric oxide |
| WO2021142472A1 (en) | 2020-01-11 | 2021-07-15 | Third Pole, Inc. | Systems and methods for nitric oxide generation with humidity control |
| US20210395905A1 (en) | 2020-06-18 | 2021-12-23 | Third Pole, Inc. | Systems and methods for preventing and treating infections with nitric oxide |
| US11975139B2 (en) | 2021-09-23 | 2024-05-07 | Third Pole, Inc. | Systems and methods for delivering nitric oxide |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6758214B2 (en) | 2000-01-28 | 2004-07-06 | Cyterra Corporation | Simple nitric oxide generator for ambulatory and/or bedside inhaled no treatment |
| CA2459891C (en) | 2001-09-05 | 2014-02-04 | Cyterra Corporation | Method and apparatus for nitric oxide generation |
| US7618594B2 (en) | 2004-08-18 | 2009-11-17 | Geno Llc | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
| AU2005277397B2 (en) | 2004-08-18 | 2011-08-25 | VERO Biotech LLC. | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
| CA2588994A1 (en) * | 2004-12-08 | 2006-06-15 | Biomarin Pharmaceutical Inc. | Methods and compositions for the treatment of pulmonary hypertension of the newborn |
| US20090197922A1 (en) * | 2006-01-24 | 2009-08-06 | The University Of Chicago | Compositions and methods for treating pulmonary hypertension |
| US7947227B2 (en) | 2007-03-23 | 2011-05-24 | Geno Llc | Kit for the conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
| JP5554723B2 (ja) | 2008-01-28 | 2014-07-23 | ゲノ エルエルシー | 二酸化窒素（ｎｏ２）から一酸化窒素（ｎｏ）への変換 |
| CA3037614A1 (en) | 2008-07-24 | 2010-01-28 | Vero Biotech LLC | Methods for diagnosing and treating a heart condition in a patient |
| US10780241B2 (en) | 2008-08-21 | 2020-09-22 | Vero Biotech LLC | Devices and methods for minimizing and treating high-altitude sickness |
| US8607785B2 (en) | 2008-08-21 | 2013-12-17 | Geno Llc | Systems and devices for generating nitric oxide |
| US8701657B2 (en) | 2008-08-21 | 2014-04-22 | Geno Llc | Systems for generating nitric oxide |
| US10960168B2 (en) | 2008-08-21 | 2021-03-30 | Vero Biotech LLC | Delivery of high concentration nitric oxide |
| US8173072B2 (en) | 2008-09-22 | 2012-05-08 | Geno Llc | Conversation of nitrogen dioxide (NO2) to nitric oxide (NO) |
| EP2445508B1 (en) | 2009-06-22 | 2018-11-14 | VERO Biotech LLC | Nitric oxide therapies |
| CA2671029A1 (en) | 2009-06-30 | 2010-12-30 | James S. Baldassarre | Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension |
| US20120093948A1 (en) * | 2009-11-20 | 2012-04-19 | Fine David H | Nitric Oxide Treatments |
| US8646445B2 (en) | 2009-11-20 | 2014-02-11 | Geno Llc | Nitric oxide delivery system |
| EP2563440A4 (en) | 2010-04-26 | 2017-06-21 | Geno LLC | Nitrosyl special connector |
| EP3777937B1 (en) | 2010-04-26 | 2024-07-24 | VERO Biotech Inc. | Delivery of ultra pure nitric oxide (no) |
| USD679366S1 (en) | 2010-04-27 | 2013-04-02 | Geno Llc | Male gas connector |
| USD688352S1 (en) | 2010-04-27 | 2013-08-20 | Geno Llc | Female gas connector |
| WO2012075420A1 (en) * | 2010-12-03 | 2012-06-07 | Geno Llc | Nitric oxide treatments |
| CA2833914A1 (en) * | 2011-05-10 | 2012-11-15 | Universite Laval | Methods for the treatment and diagnostic of pulmonary arterial hypertension |
| CA2837341C (en) | 2011-05-27 | 2021-10-19 | Geno Llc | Method of determining vasoreactivity using inhaled nitric oxide |
| EP3209360B1 (en) | 2014-10-20 | 2022-12-07 | VERO Biotech LLC | Nitrogen dioxide storage cassette |
-
2012
- 2012-05-24 CA CA2837341A patent/CA2837341C/en active Active
- 2012-05-24 JP JP2014512110A patent/JP2014527025A/ja active Pending
- 2012-05-24 EP EP12793863.7A patent/EP2713723B1/en active Active
- 2012-05-24 AU AU2012262534A patent/AU2012262534B2/en not_active Ceased
- 2012-05-24 WO PCT/US2012/039401 patent/WO2012166534A1/en not_active Ceased
-
2013
- 2013-01-07 US US13/735,558 patent/US11154210B2/en active Active
-
2017
- 2017-03-27 JP JP2017061811A patent/JP2017165731A/ja not_active Ceased
-
2019
- 2019-02-28 JP JP2019035311A patent/JP2019131556A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014527025A5 (cg-RX-API-DMAC7.html) | ||
| CA2837341C (en) | Method of determining vasoreactivity using inhaled nitric oxide | |
| JP2012505014A5 (cg-RX-API-DMAC7.html) | ||
| JP2013543491A5 (cg-RX-API-DMAC7.html) | ||
| JP2017538554A5 (cg-RX-API-DMAC7.html) | ||
| MX375241B (es) | Métodos y herramientas relacionadas con la administración de medio de contraste. | |
| JP2016510040A5 (cg-RX-API-DMAC7.html) | ||
| CN203723482U (zh) | 有口袋的口罩 | |
| CN203042227U (zh) | 一种防脱落压力换能器 | |
| CN205126426U (zh) | 吸氧管道收纳袋 | |
| CN202942529U (zh) | 一种用于自体血液回收的吸引头 | |
| Syed | Nitric oxide/nitroglycerin | |
| Weiler et al. | C108 ADVANCES IN LUNG FUNCTION ASSESSMENT: High-Flow Nasal Cannula Offers Greater Reduction Of Effort Of Breathing In Children Of Lower Weight | |
| CN207136982U (zh) | 一种急救推车 | |
| Weiler et al. | High-flow nasal cannula offers greater reduction of effort of breathing in children of lower weight | |
| CN203017517U (zh) | 一种防晕车装置 | |
| CN205994829U (zh) | 一种改良式吸氧装置 | |
| Duan et al. | Evaluation of shunting flow differences in varied conditions in a simulated adult CPB model during normothermia | |
| Miyagawa et al. | The combined effects of manual chest squeezing coordinated expiration during exercise in patients with chronic obstructive pulmonary disease (COPD) | |
| Dowman et al. | B109 HIGHLIGHTS AND ADVANCES IN PULMONARY REHABILITATION: Effect Of Supplemental Oxygen On Exercise Response In Patients With Idiopathic Pulmonary Fibrosis | |
| CN203842136U (zh) | 一种新型氧气呼吸器 | |
| CN204379923U (zh) | 一种雾化剂吸入装置 | |
| CN204207804U (zh) | 户外紧急锁血带 | |
| Parke et al. | An analysis of the pressure delivered throughout the respiratory cycle during use of nasal high flow oxygen therapy | |
| CN201052164Y (zh) | 一种止血带 |